logo
logo

Maxcyte, Inc. announced it raised $760,000 in an initial filing from an offering of $760,000

Sep 29, 2016almost 9 years ago

Amount Raised

$760,000

Round Type

seed

RockvilleBiotechnology

Company Information

Company

SeQure Dx

Location

22 FIRSTFIELD ROAD

Rockville, Maryland, United States

About

Founded in 2008, the firm has over $450 million in capital under management with a mission to bring bench-to-bedside innovations to market to solve unmet medical needs for the benefit of patients worldwide. SeQure Dx was founded on exclusive licensure of GUIDE-seq, ONE-seq and related assay technologies for detection of off-target gene-editing events. ”Nancy Hong, PhD, managing director at RiverVest Venture Partners said: “RiverVest is thrilled to participate in this transformative technology arena. SeQure Dx is uniquely positioned to aid gene-editing innovators in providing safe patient access to novel treatments, and we are pleased to support SeQure Dx through this accelerated growth period.”Carl Berke, PhD, a partner at Mass General Brigham Ventures, said, “Mass General Brigham Ventures has the privilege of supporting the development of this important contribution to the future of cell and gene therapy through the dedicated efforts of SeQure Dx.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People